期刊文献+

敲低DNA依赖蛋白激酶催化亚基(DNA-PKcs)抑制Bel7402/5-Fu耐药肝癌细胞的细胞周期及机制 被引量:2

Knockdown of DNA-PKcs inhibits cell cycle and its mechanism of drug-resistant Bel7402/5-Fu hepatocellular carcinoma cells
下载PDF
导出
摘要 目的研究DNA依赖蛋白激酶催化亚基(DNA-PKcs)基因沉默后对Bel7402/5-氟尿嘧啶(5-Fu)肝癌耐药细胞的细胞周期及机制的影响,探讨DNA-PKcs影响化疗敏感性的相关机制。方法采用MTT法检测Bel7402/5-Fu细胞转染siDNA-PKcs后,对5-Fu、阿霉素(ADM)的敏感性;采用阳离子脂质体法将siDNA-PKcs寡核苷酸片段转染Bel7402/5-Fu细胞;流式细胞术检测细胞周期;Western blot法检测细胞P21、细胞周期蛋白B1(cyclin B1)、细胞分裂周期蛋白2(CDC2)的蛋白表达情况;实时定量PCR检测细胞毛细血管扩张共济失调突变基因(ATM)、p53的mRNA水平,Western blot法检测细胞ATM、P53蛋白水平。结果敲低细胞DNA-PKcs水平后,siDNA-PKcs组5-Fu、ADM的半数抑制浓度(IC50)明显降低,S期细胞减少、G2/M期细胞增多,细胞周期抑制因子P21蛋白水平增加,cyclin B1、CDC2蛋白水平降低,ATM、p53的mRNA及蛋白水平增加。结论敲低DNA-PKcs水平,增加P21蛋白水平,同时抑制cyclin B1、CDC2蛋白水平,诱导Bel7402/5-Fu细胞G2/M期阻滞,其机制可能与ATM-p53信号途径有关。 Objective To study the effect of the knock-down of the DNA-dependent protein kinase catalytic subunit( DNA-PKcs) on the cell cycle of the multidrug-resistant( MDR) Bel7402/5-Fu hepatocellular carcinoma cells and its MDR mechanism. Methods After cationic liposome-mediated siDNA-PKcs oligonucleotide transfection,the drug sensitivity of Bel7402/5-Fu cells to 5-fluorouracil( 5-Fu) and adriamycin( ADM) was determined by MTT assay; the cell cycle were detected by flow cytometry; meanwhile,the protein expressions of cel cycle-related proteins P21,cel cycle protein B1( cyclin B1),cel cycle division protein 2( CDC2) were tested by Western blotting; the expressions of ataxia telangiectasia mutated( ATM)and p53 at both mRNA and protein levels were detected by real-time PCR and Western blot analysis. Results The MTT results showed siDNA-PKcs increased the chemotherapeutic sensitivity of Bel7402/5-Fu cells to 5-Fu and ADM. The flow cytometric analysis showed siDNA-PKcs decreased the percentage of S-phase cells but increased the percentage of G2/M phase cells. Western blotting showed siDNA-PKcs increased the protein expression of P21 but decreased cyclin B1 and CDC2 proteins. In addition,siDNA-PKcs also increased the expressions of ATM and p53. Conclusion DNA-PKcs silencing increases P21 while decreases cyclin B1 and CDC2 expressions,and finally induces G2/M phase arrest in Bel7402/5-Fu cells,which may be related to ATM-p53 signaling pathway.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2017年第12期1647-1651,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 贵州省社法攻关项目[黔科合SY(2013)3008] 2016年硕士科研启动资金[F-829]
关键词 DNA依赖性蛋白激酶催化亚基 耐药肝癌细胞 细胞周期 机制 DNA-dependent protein kinase catalytic subunit multidrug-resistant hepatocellular carcinoma cells cell cyclemechanism
  • 相关文献

参考文献2

二级参考文献22

  • 1戴春岭,符立梧.肿瘤多药耐药逆转剂的研究进展[J].中国药理学通报,2005,21(5):513-518. 被引量:39
  • 2解霞,郝立宏,高清波,杨佩满.川芎嗪逆转肿瘤多药耐药性及其机制的研究[J].中华肿瘤防治杂志,2006,13(18):1368-1370. 被引量:19
  • 3王鑫,王洁,张燕,高志光.肿瘤细胞耐药机制的研究进展[J].癌症进展,2007,5(1):73-78. 被引量:2
  • 4王天晓,李明.肿瘤多药耐药性及其逆转策略[J].肿瘤防治研究,2007,34(10):804-807. 被引量:9
  • 5Tsuruo T,Naito M,Tomida A,et al.Molecular targeting therapy of cancer:drug resistance,apoptosis and survival signal[J].Cancer Science,2003,94(1):15-21. 被引量:1
  • 6Biedler,J L,Riehm H.Cellular resistance to actinomycin D in Chinese hamster cells in vitro:cross-resistance,radioautographic,and cytogenetic studies[J].Cancer Research,1970,30(4):1174-1184. 被引量:1
  • 7Goldman B.Multidrug resistance:can new drugs help chemotherapy score against cancer?[J].National Cancer Institute,2003,95(4):255-257. 被引量:1
  • 8Zhang D,Fan D.New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives[J].Furure Oncology,2010,6(4):527-537. 被引量:1
  • 9Li Y,Revalde J L,Reid G,et al.Interactions of dietary phytochemicals with ABC transporters:possible implications for drug disposition and multidrug resistance in cancer[J].Drug Metabolism,2010,42(4):590-611. 被引量:1
  • 10Ferrari S,Bertoni F,Zanella L,et al.Evaluation of P-glycoprotein,HER-2/ErbB-2,p53,and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade[J].Osteosarcoma Cancer,2004,100(9):1936-1942. 被引量:1

共引文献1

同被引文献28

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部